Average Co-Inventor Count = 3.60
ph-index = 37
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The Johns Hopkins University (229 from 3,663 patents)
2. Duke University (18 from 1,999 patents)
3. University of Utah Research Foundation (11 from 1,636 patents)
4. Cancer Institute (10 from 25 patents)
5. Morphotek, Inc. (9 from 65 patents)
6. Other (7 from 832,347 patents)
7. Imperial Chemical Industries Limited (3 from 3,840 patents)
8. Genzyme Corporation (3 from 777 patents)
9. Biomed Valley Discoveries, Inc. (3 from 39 patents)
10. Zeneca Limited (2 from 854 patents)
11. University of Texas System (1 from 5,401 patents)
12. State University of New York (1 from 1,970 patents)
13. Cancer Institute, Japanese Foundation for Cancer Research (1 from 4 patents)
14. Utrecht University (1 from 3 patents)
15. Pharmagenics, Inc. (1 from 3 patents)
238 patents:
1. 12427173 - Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies
2. 12359250 - Bottleneck sequencing
3. 12275996 - Head and neck squamous cell carcinoma assays
4. 12252743 - Safe sequencing system
5. 12209281 - Safe sequencing system
6. 12195803 - Methods and materials for assessing and treating cancer
7. 12116628 - Rapid aneuploidy detection
8. 12054781 - Detection of tumor-derived DNA in cerebrospinal fluid
9. 12006544 - Safe sequencing system
10. 11807662 - MANAbodies and methods of using
11. 11773440 - Safe sequencing system
12. 11753468 - Checkpoint blockade and microsatellite instability
13. 11718668 - Checkpoint blockade and microsatellite instability
14. 11667976 - TERT promoter mutations in urothelial neoplasia
15. 11649287 - Checkpoint blockade and microsatellite instability